Avenue Therapeutics, Inc. (ATXI)
OTCMKTS
· Delayed Price · Currency is USD
0.220
+0.043 (24.22%)
At close: Mar 6, 2026
Avenue Therapeutics Employees
Avenue Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
$702,000
Profits / Employee
-$1,872,000
Market Cap
724.82K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Windtree Therapeutics | 14 |
| Altamira Therapeutics | 11 |
| Bio-Path Holdings | 10 |
| Hepion Pharmaceuticals | 22 |
| Lipella Pharmaceuticals | 7 |
| Scorpius Holdings | 91 |
Avenue Therapeutics News
- 1 year ago - Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 1 year ago - Avenue Therapeutics to Participate in Maxim Group's 2024 Healthcare Virtual Summit - GlobeNewsWire
- 1 year ago - Avenue Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 1 year ago - Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 1 year ago - Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - GlobeNewsWire
- 1 year ago - Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease) - GlobeNewsWire
- 1 year ago - Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 years ago - Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds - GlobeNewsWire